What is Abridge?
Abridge offers a sophisticated solution for managing health-related conversations. By recording and transcribing in-person and telemedicine appointments, the platform generates interactive transcripts that pinpoint crucial medical information. This technology aims to bridge the understanding gap, ensuring all parties involved—patients, their families, and healthcare providers—are aligned on key medical points, thereby fostering better adherence to treatment plans and improving overall care coordination. The company's focus on clarity and accessibility in health communication positions it as a key player in the evolving digital health landscape.
How much funding has Abridge raised?
Abridge has raised a total of $757.5M across 6 funding rounds:
Other Financing Round
$15M
Series A
$12.5M
Series B
$30M
Series C
$150M
Series D
$250M
Series E
$300M
Other Financing Round (2020): $15M with participation from Pillar, Bessemer Venture Partners, KdT Ventures, Union Square Ventures, and University of Pittsburgh Medical Center
Series A (2022): $12.5M led by Union Square Ventures, Bessemer Venture Partners, and Wittington Ventures
Series B (2023): $30M supported by Scan Group, Spark Capital, LifePoint Health, Mayo Clinic, Bessemer Venture Partners, and Uc Investments
Series C (2024): $150M featuring Mass General Brigham, CVS Health, Redpoint Ventures, Union Square Ventures, Bessemer Venture Partners, Wittington Ventures, Lightspeed Venture Partners, and Kaiser Permanente
Series D (2025): $250M backed by CapitalG, Bessemer Venture Partners, California Health Care Foundation, IVP, Lightspeed Venture Partners, CVS Health, and Elad Gil
Series E (2025): $300M with participation from Andreessen Horowitz, Lightspeed Venture Partners, and CVS Health
Key Investors in Abridge
Andreessen Horowitz
Andreessen Horowitz is a prominent venture capital firm known for investing in both early-stage and growth-stage technology companies, with a focus on transformative market opportunities.
CVS Health
CVS Health is a major integrated healthcare company focused on delivering affordable, high-quality care and improving health and well-being through connected experiences.
CapitalG
CapitalG is Alphabet's independent growth fund that invests capital and expertise to support remarkable entrepreneurs and transformational companies in accelerating their growth, typically focusing on growth-stage tech companies.
What's next for Abridge?
With substantial enterprise-level funding and a recent major strategic investment, Abridge is poised for accelerated growth and expansion. The company's trajectory suggests a focus on scaling its operations, enhancing its AI capabilities, and potentially broadening its market reach within the healthcare ecosystem. Future developments may include deeper integrations with electronic health record systems, expanded partnerships with health systems and payers, and further refinement of its transcript analysis to provide more actionable insights for both patients and providers. This sustained capital infusion signals a strong commitment to solidifying Abridge's role as a leader in health communication technology.
See full Abridge company page
